CYP2C19
MOLECULAR TARGETcytochrome P450 family 2 subfamily C member 19
CYP2C19 (cytochrome P450 family 2 subfamily C member 19) is targeted by 334 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting CYP2C19
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
Showing top 50 of 334 compounds. Use the BiohacksAI search to explore all CYP2C19 modulators.
About CYP2C19 as a Drug Target
CYP2C19 (cytochrome P450 family 2 subfamily C member 19) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 334 compounds with documented CYP2C19 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
CYP2C19 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.